Disposal of investigational products/study drugs

Investigators should maintain records of investigational product/study drug (IP) return to the sponsor or alternative disposition of unused product(s). This procedure therefore describes the process for returning IP to the sponsor or arranging for their destruction at the trial site. This procedure may be supplemented with a trial-specific pharmacy manual or process document(s)